Melissa Baird compensation by year
Hims & Hers Health Summary Compensation Table · all 7 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Salary | $316,667 | $434,219 | $466,913 | $468,000 | $490,000 | $490,000 | $341,292 |
| Bonus | $12,684 | $0 | $330,933 | $0 | $0 | $0 | $0 |
| Stock awards | — | $1,289,200 | $3,977,305 | $1,499,999 | $5,111,076 | $7,962,596 | $8,048,579 |
| Option awards | $146,085 | $2,522,193 | — | $3,941,333 | $600,084 | $0 | $0 |
| Non-equity incentive | — | $80,933 | — | $446,671 | $561,600 | $628,375 | $0 |
| Pension and deferred compensation | — | $0 | — | — | $0 | $0 | $0 |
| All other | — | $20,418 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 |
| Total | $475,436 | $4,367,811 | $4,778,151 | $6,359,003 | $6,765,760 | $9,083,971 | $8,392,871 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Hims & Hers Health, Inc. DEF 14A filed April 28, 2026, accession 0001773751-26-000060, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Hims & Hers Health, Inc. filed document, accession 0001773751-26-000060. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 235,205 | $7,637,106 | — |
| PSU | 182,529 | $5,926,717 | — |
| RSU | 160,754 | $5,219,682 | — |
| RSU | 81,487 | $2,645,883 | — |
| RSU | 18,713 | $607,611 | — |
| Option | 69,215 | — | $5.01 |
| Option | 30,814 | — | $11.53 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Hims & Hers Health, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Hims & Hers Health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mohamed Elshenawy | Chief Technology Officer | $60,869,746 |
| Andrew Dudum | Chief Executive Officer and Chairman | $22,958,907 |
| Nader Kabbani | Former Chief Operating Officer | $14,862,305 |
| Yemi Okupe | Chief Financial Officer | $8,398,808 |
| Melissa Baird · this page | Former Chief Operating Officer | $8,392,871 |
| Mike Chi | Chief Operating Officer (previously Chief Commercial Officer) | $7,727,713 |
| Soleil Boughton | Chief Legal Officer | $4,796,709 |
Melissa Baird's compensation dossier, Hims & Hers Health
You have read Melissa Baird's totals and holdings. The dossier adds each equity grant Hims & Hers Health disclosed for Melissa Baird and Hims & Hers Health's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Hims & Hers Health compensation record
free company briefThis page is one person within Hims & Hers Health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Hims & Hers Health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Hims & Hers Health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Hims & Hers Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order HIMS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.